Methylene blue is a cationic thiazine dye that has diverse biological activities. It inhibits the catalytic function of inducible and constitutive nitric oxide synthases via oxidation of enzyme-bound ferrous iron. Methylene blue also inhibits monoamine oxidase (MAO) and increases the activity of mitochondrial cytochrome C oxidase (complex IV). In vivo, methylene blue stabilizes systemic circulation without increasing peripheral resistance, decreases lipid peroxidation, and reduces anoxic tissue injury in brain and heart in a porcine model of global ischemia and reperfusion injury. It inhibits MAO activity in brain and reduces the age-related decline in grip strength and spatial memory in old mice when administered in drinking water at a concentration of 250 μM. Methylene blue (15, 30, and 60 mg/kg) also reduces immobility time in the forced swim test in mice, indicating antidepressant-like activity. Methylene blue is commonly used to stain cells and tissues in research.
Methylene Blue (hydrate) is a guanylyl cyclase (sGC), monoamine oxidase A (MAO-A) and NO synthase (NOS) inhibitor. Methylene blue is a vasopressor and is often used as a dye in several medical procedures. Methylene blue hydrate through the nitric oxide syntase/guanylate cyclase signalling pathway to reduce prepulse inhibition. Methylene blue hydrate is a REDOX cycling compound and able to cross the blood-brain barrier. Methylene blue hydrate is a Tau aggregation inhibitor. Methylene blue hydrate reduces cerebral edema, attenuated microglial activation and reduced neuroinflammation.
体外研究
Methylene Blue (hydrate) (4.5 μM; BV2 microglia) alters the immune profile of LPS-activated BV2 microglia and decreased the level of CD14, IL-1β, TNF-α, and CCL2 mRNA.
体内研究
Methylene Blue (hydrate) (50 and 100 mg/kg; i.p.; once, for 25 min; male NMRI mice) reduces absent prepulse inhibition.
Methylene Blue (hydrate) (20 and 40 mg/kg; p.o.; daily, for 6 months; CaMKIIα-tTA transactivator mice) preserves cognition in mice expressing full-length pro-aggregant human Tau.
Methylene Blue (hydrate) (2 mg/kg; i.v.; once, for 1 d; TBI-treated male BALB/c mice) reduces TBI-induced edema and neuroinflammation and reduces acute depression-like behavior.
Methylene Blue (hydrate) (2 mg/kg; i.v.; once, for 1 d; TBI-treated male BALB/c mice) reduces the percentage of inflammatory factor.
Animal Model:
Male NMRI mice
Dosage:
50 and 100 mg/kg
Administration:
Intraperitoneal injection; once, for 25 minutes
Result:
Reduced the prepulse inhibition and reduced the increase in locomotor activity caused by phencyclidine (PCP).
Animal Model:
CaMKIIα-tTA transactivator mice
Dosage:
20 and 40 mg/kg
Administration:
Oral administration; daily, for 6 months
Result:
Inhibited Tau aggregation in CaMKIIα-tTA transactivator mice.
Animal Model:
TBI-treated male BALB/c mice
Dosage:
2 mg/kg
Administration:
Intravenous injection; once, for 1 day
Result:
Decreased the level of CD14, IL-1β, TNF-α, and CCL2 mRNA.
Animal Model:
TBI-treated male BALB/c mice
Dosage:
2 mg/kg
Administration:
Intravenous injection; once, for 1 day
Result:
Reduced the percentage of myeloid (CD11b+/GR1+) cells, reduced IL-1β and enhanced IL10 expression in microglia.
分子式
C16H18N3S.Cl.XH2O
CAS号
122965-43-9
中文名称
次甲基兰水合物;亚甲基兰
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
2-8°C, sealed storage, away from moisture and light
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
溶解性数据
DMSO : 7.14 mg/mL (Need ultrasonic)
H2O : 2 mg/mL (ultrasonic and warming and heat to 60°C)